Track the Indegene stock price and the full insider trade history of the company, a publicly traded company based in India. Shares are listed on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €139.8bn. The latest transaction was filed on 28 August 2026 (Disposal). Among the most active insiders: BPC Genesis Fund I- A SPV Ltd. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Indegene 是一家专注于为制药和生物制药公司提供数字健康解决方案和营销服务的公司。它提供从战略到执行的服务,并整合了先进技术。